KK mentions challenges Cynata has encountered with the trial, including the location of the trial centers vs where the patients are located and what steps Cynata has undertaken to overcome that (34:54 mins onwards).
He also addressed an issue of patients with DFU - the lack of getting proper care. Given that as a result of this trial all groups, including the control grou, have access to adequate care, and therefore show an improvement compared to the "real-world", albeit not dramatic and by itself won't solve the problem.
On a side note, there is an additional Research Program currently underway at Monashm, comparing MSCs from different sources:
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)